Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
NCT03198286 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2025-04-29
Summary
This pilot clinical trial studies how well the Carevive Survivor Care Planning System works in improving quality of life in breast cancer survivors. A personalized survivor care plan includes a summary of a patient's cancer treatment and a customized survivor care plan and may provide beneficial information and resources.
Conditions
- Stage I Breast Cancer
- Stage I Cervical Cancer
- Stage I Ovarian Cancer
- Stage I Uterine Corpus Cancer
- Stage IA Breast Cancer
- Stage IA Cervical Cancer
- Stage IA Ovarian Cancer
- Stage IA Uterine Corpus Cancer
- Stage IB Breast Cancer
- Stage IB Cervical Cancer
- Stage IB Ovarian Cancer
- Stage IB Uterine Corpus Cancer
- Stage IC Ovarian Cancer
- Stage II Breast Cancer
- Stage II Cervical Cancer
- Stage II Ovarian Cancer
- Stage II Uterine Corpus Cancer
- Stage IIA Breast Cancer
- Stage IIA Cervical Cancer
- Stage IIA Ovarian Cancer
- Stage IIB Breast Cancer
- Stage IIB Cervical Cancer
- Stage IIB Ovarian Cancer
- Stage IIC Ovarian Cancer
- Stage III Breast Cancer
- Stage III Cervical Cancer
- Stage III Ovarian Cancer
- Stage III Uterine Corpus Cancer
- Stage IIIA Breast Cancer
- Stage IIIA Cervical Cancer
- Stage IIIA Ovarian Cancer
- Stage IIIA Uterine Corpus Cancer
- Stage IIIB Breast Cancer
- Stage IIIB Cervical Cancer
- Stage IIIB Ovarian Cancer
- Stage IIIB Uterine Corpus Cancer
- Stage IIIC Breast Cancer
- Stage IIIC Ovarian Cancer
- Stage IIIC Uterine Corpus Cancer
Interventions
- OTHER
-
Informational Intervention
Receive treatment summary and survivor care plan
Sponsors & Collaborators
-
Sidney Kimmel Cancer Center at Thomas Jefferson University
lead OTHER
Principal Investigators
-
Andrea Barsevick, PhD · Sidney Kimmel Cancer Center at Thomas Jefferson University
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-08-01
- Primary Completion
- 2015-08-01
- Completion
- 2016-10-31
Countries
- United States
Study Locations
More Related Trials
-
Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab and Chemotherapy in Breast Cancer
NCT01190345 ·Status: COMPLETED ·Phase: PHASE2
-
Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice
NCT04297384 ·Status: COMPLETED ·Phase: NA
-
MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer
NCT01319539 ·Status: TERMINATED ·Phase: PHASE2
-
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
NCT05020860 ·Status: RECRUITING ·Phase: PHASE2
-
Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer
NCT05826964 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer
NCT00365417 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer
NCT02059876 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer
NCT00050167 ·Status: COMPLETED ·Phase: PHASE1
-
Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival
NCT02364557 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
NCT00861705 ·Status: COMPLETED ·Phase: PHASE2
-
Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
NCT03628066 ·Status: COMPLETED ·Phase: PHASE2
-
Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer
NCT00161291 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer
NCT02846428 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents
NCT00191438 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy in Treating Women With Stage III Breast Cancer
NCT00002696 ·Status: SUSPENDED ·Phase: PHASE3
-
Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer
NCT00256243 ·Status: COMPLETED ·Phase: PHASE2
-
Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer
NCT00544167 ·Status: COMPLETED ·Phase: NA
-
Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer
NCT00678626 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluation of Improvements in Patient-reported Quality of Life
NCT06002022 ·Status: RECRUITING ·Phase: NA
-
Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery
NCT00769470 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer
NCT00068341 ·Status: COMPLETED ·Phase: PHASE2
-
Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC
NCT05720260 ·Status: RECRUITING ·Phase: PHASE2
-
Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breast Cancer and Their Families or Caregivers
NCT01043003 ·Status: COMPLETED ·Phase: NA
-
A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
NCT05262400 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Biological Therapy in Treating Women With Stage IV Breast Cancer
NCT00027807 ·Status: COMPLETED ·Phase: PHASE1